Skip to content

Human Research Program Flight Thigh Cuff

Mitigating Headward Fluid Shifts With Venoconstrictive Thigh Cuffs During Spaceflight

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06476106
Enrollment
10
Registered
2024-06-26
Start date
2023-03-24
Completion date
2030-05-14
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Venoconstrictive Thigh Cuffs (VTC) are being evaluated to determine the effectiveness at reversing the headward fluid shift that occurs during weightlessness. If successful, future studies may be done to implement these as a CM to SANS. To support this effort, participants will participate in 2 preflight study sessions consisting of a VTC fit check and a baseline data collection without and with the VTC donned. Participants will also participate in 3 inflight study sessions: a VTC fit check on flight day 30 (FD30) and two separate data collection sessions on flight day 45 (FD45) and 45 days before landing (R-45). During the two in-flight data collection days, participants will be studied before and for up to 6 hours after donning the VTC.

Interventions

DEVICEVenoconstrictive Thigh Cuff (VTC)

The VTC is an adjustable fabric cuff that is worn on the upper thighs to retain some fluid in the legs. It consists of wide straps and a buckle which allow it to be tightened, then velcro to secure the strap in the tightened position. There is also lacing that can be tightened for micro adjustments. Imbedded within the fabric strap is a bladder that is not used for increasing tightness but allows the pressure of the cuff to be measured and tracked.

Sponsors

National Aeronautics and Space Administration (NASA)
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Astronauts participating in missions that are ≥2 months

Exclusion criteria

* Having known allergies to proparacaine hydrochloride ophthalmic solution precludes participation in this study * Use of ethinyl estradiol Combined Oral Contraceptive (COC) pills precludes participation in this study * Having increased risk of venothromboembolism (VTE) based on preflight thrombosis/clotting related biomarkers precludes participation in this study

Design outcomes

Primary

MeasureTime frameDescription
Internal Jugular Vein (IJV) areaThigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before returnMeasured using Ultrasound.
IJV pressureThigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before returnMeasured using the VeinPres device during Ultrasound.
Intraocular Pressure (IOP)Thigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before returnMeasured using the Pneumatonometer.
stroke volumeThigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before returnMeasured from data collected during Ultrasound.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026